These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11007781)

  • 1. Radicicol binds and inhibits mammalian ATP citrate lyase.
    Ki SW; Ishigami K; Kitahara T; Kasahara K; Yoshida M; Horinouchi S
    J Biol Chem; 2000 Dec; 275(50):39231-6. PubMed ID: 11007781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
    Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
    Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
    Sharma SV; Agatsuma T; Nakano H
    Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
    Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
    Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
    Shiotsu Y; Neckers LM; Wortman I; An WG; Schulte TW; Soga S; Murakata C; Tamaoki T; Akinaga S
    Blood; 2000 Sep; 96(6):2284-91. PubMed ID: 10979978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate Sam68 and retards subsequent exit from mitosis of Src-transformed cells.
    Pillay I; Nakano H; Sharma SV
    Cell Growth Differ; 1996 Nov; 7(11):1487-99. PubMed ID: 8930398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
    Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
    Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
    J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.
    Kwon HJ; Yoshida M; Muroya K; Hattori S; Nishida E; Fukui Y; Beppu T; Horinouchi S
    J Biochem; 1995 Jul; 118(1):221-8. PubMed ID: 8537316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.
    Gadelle D; Bocs C; Graille M; Forterre P
    Nucleic Acids Res; 2005; 33(7):2310-7. PubMed ID: 15849317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host cell factor requirement for hepatitis C virus enzyme maturation.
    Waxman L; Whitney M; Pollok BA; Kuo LC; Darke PL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13931-5. PubMed ID: 11707594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 chaperones wild-type p53 tumor suppressor protein.
    Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
    J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
    Thulasiraman V; Matts RL
    Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of radicicol analogues.
    Soga S; Shiotsu Y; Akinaga S; Sharma SV
    Curr Cancer Drug Targets; 2003 Oct; 3(5):359-69. PubMed ID: 14529387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSP90 inhibitors alter capsaicin- and ATP-induced currents in rat dorsal root ganglion neurons.
    McDowell TS; Yukhananov RY
    Neuroreport; 2002 Mar; 13(4):437-41. PubMed ID: 11930156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins.
    Rosenhagen MC; Young JC; Wochnik GM; Herr AS; Schmidt U; Hartl FU; Holsboer F; Rein T
    Biol Chem; 2001 Mar; 382(3):499-504. PubMed ID: 11347901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
    Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
    Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
    Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
    Guarnieri MT; Zhang L; Shen J; Zhao R
    J Mol Biol; 2008 May; 379(1):82-93. PubMed ID: 18440021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.
    Shen Y; Xie Q; Norberg M; Sausville E; Vande Woude G; Wenkert D
    Bioorg Med Chem; 2005 Aug; 13(16):4960-71. PubMed ID: 15978816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.